Professional Documents
Culture Documents
创新药群体药代动力学研究申报资料的探讨 李健
创新药群体药代动力学研究申报资料的探讨 李健
中国临床药理学与治疗学
◇ 临床药理学 ◇ 中国药理学会主办
CN 34-1206 / R,ISSN 1009-2501
http: / / www. cjcpt. com
2020 May; 25( 5) : 546-549
创新药群体药代动力学研究申报资料的探讨
李 健,杨进波,王玉珠
国家药品监督管理局药品审评中心 ,北京 100022
ABSTRACT Population pharmacokinetics ( Pop- application. This article conducts a preliminary dis-
PK) is an analytical method that can quantify the cussion on new drug PopPK study and its reporting
variability of drug concentration among individuals. format and content,with reference to the require-
It is widely used in various stages of new drug re- ments in relevant guidelines as well as previous re-
searches from non-clinic to clinic. With the rapid view experiences,for the discussion or reference of
development of PopPK,more and more sponsors are industries and researchers.
keen to comprehensively analyze the in vivo proces- KEYWORDS new drug; population pharmacoki-
ses of new drugs as well as its influencing factors u- netics; modeling and simulation; covariate analysis;
sing modeling and simulation methods. Several study report
guidelines have been issued to recommend the use of
本文编辑: 李 娟
PopPK in China. However,no explicit requirement
of PopPK study report has been issued for regulatory